LISA CEJKA: Open Payments
NPI 1134531593 · LA VERGNE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 18 payments from 7 companies in 2025. Trend: 2023 $86 · 2024 $234 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $18 |
Products named: CAPLYTA, Ozempic, Auvelity, Rybelsus, QULIPTA, REXULTI, AIRSUPRA, Dyanavel XR.
Industry payments across TN — which companies pay providers there.
